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A B S T R A C T
Background
This is the first update of a Cochrane review published in Issue 5, 2010 on transcutaneous electrical nerve stimulation (TENS) for
phantom pain and stump pain following amputation in adults. Pain may present in a body part that has been amputated (phantom
pain) or at the site of amputation (stump pain), or both. Phantom pain and stump pain are complex and multidimensional and the
underlying pathophysiology remains unclear. The condition remains a severe burden for those who are affected by it. The mainstay
treatments are predominately pharmacological, with increasing acknowledgement of the need for non-drug interventions. TENS has
been recommended as a treatment option but there has been no systematic review of available evidence. Hence, the effectiveness of
TENS for phantom pain and stump pain is currently unknown.
Objectives
To assess the analgesic effectiveness of TENS for the treatment of phantom pain and stump pain following amputation in adults.
Search methods
For the original version of the review we searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE,
EMBASE, PsycINFO, AMED, CINAHL, PEDRO and SPORTDiscus (February 2010). For this update, we searched the same
databases for relevant randomised controlled trials (RCTs) from 2010 to 25 March 2015.
Selection criteria
We only included RCTs investigating the use of TENS for the management of phantom pain and stump pain following an amputation
in adults.
Data collection and analysis
Two review authors independently assessed trial quality and extracted data. We planned that where available and appropriate, data from
outcome measures were to be pooled and presented as an overall estimate of the effectiveness of TENS.
Main results
In the original review there were no RCTs that examined the effectiveness of TENS for the treatment of phantom pain and stump pain
in adults. For this update, we did not identify any additional RCTs for inclusion.
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Authors’ conclusions
There were no RCTs to judge the effectiveness of TENS for the management of phantom pain and stump pain. The published literature
on TENS for phantom pain and stump pain lacks the methodological rigour and robust reporting needed to confidently assess its
effectiveness. Further RCT evidence is required before an assessment can be made. Since publication of the original version of this
review, we have found no new studies and our conclusions remain unchanged.
P L A I N L A N G U A G E S U M M A R Y
Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults
Pain may present in a body part that has been amputated (phantom pain) or at the site of amputation (stump pain), or both. Phantom
pain and stump pain are complex conditions and affect up to 80% of amputees.The underlying causes are not fully understood. Drug
therapy is the most common treatment yet the condition remains poorly managed. The need for non-drug interventions has been
recognised and TENS may have an important role to play.
TENS is an inexpensive, safe and easy to use analgesic technique. TENS is administered using a battery-powered portable device, which
generates electrical currents that are delivered to the skin to activate underlying nerves.
An updated search of various databases in March 2015 found no studies that met the eligibility criteria for inclusion in this review.
It was not possible to judge the effectiveness of TENS for phantom pain and stump pain.
It was not possible to assess the risk of harm from using TENS for phantom pain and stump pain.
A large, multicentre randomised controlled trial of TENS for phantom pain and stump pain is needed.
B A C K G R O U N D
This review is the first update of a previously published review
in the Cochrane Database of Systematic Reviews (2010, Issue 5)
(Mulvey 2010).
Description of the condition
Following amputation up to 80% of patients report pain that af-
fects quality of life and hinders rehabilitation, including the use
of prosthetic limbs (Ephraim 2005; Nikolajsen 2001). Pain may
present in a body part that has been amputated (phantom pain)
or at the site of amputation (stump pain), or both (Wilson 2008).
Non-painful sensations may also present in a phantom body part
or a stump, or both (Nikolajsen 2001).Often patients present with
a unique combination of symptoms (Nikolajsen 2001; Wiffen
2006). The underlying pathophysiology is unclear, although it is
generally accepted that nociceptive and neuropathic processes are
involved and that neuropathic changes include reorganisation and
adaptation within the peripheral and central nervous systems (Flor
2002). Multimodal treatment strategies are used including anal-
gesics, muscle relaxants, vasodilators, sympathetic blocks, sympa-
thectomies, surgical revision of the stump, stimulation-induced
analgesic techniques and mirror box therapy (Flor 2002; Hanling
2010; Sherman1994; Sindrup1999).Despite amultitude of treat-
ments, a study of 92 amputees revealed that only 9%were pain free
(Smith 1999). In 2002, a systematic review of available treatment
regimes concluded that it was not possible to determine optimal
treatments for the management of phantom limb pain based on
available evidence (Halbert 2002).
Description of the intervention
Transcutaneous electrical nerve stimulation (TENS) is a technique
that delivers pulsed electrical currents across the intact surface
of the skin to stimulate peripheral nerves (Johnson 2014; Walsh
1997). TENS is principally used to relieve pain and is administered
using a ’standard TENS device’ that consists of a battery-powered
portable machine that generates electrical currents, which are de-
livered through the skin via electrodes attached to the skin surface.
TENS is safe, inexpensive and can be self administered. TENS is
contraindicated for patients with electronic implants, such as car-
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diac pacemakers and implantable cardioverter defibrillators and
precautions include pregnancy, epilepsy, active malignancy, deep-
vein thrombosis, and frail or damaged skin (Houghton 2010).
TENS is used as a stand-alone treatment and in combination with
other treatments for a wide variety of acute and chronic pains,
including phantom pain and stump pain.
How the intervention might work
TENS can be used to stimulate large diameter A-beta afferents
to elicit segmental analgesia (conventional TENS) or to stimulate
smaller diameter A-delta afferents to elicit extrasegmental anal-
gesia (acupuncture-like TENS) (Charlton 2005; Johnson 2008;
Vance 2014). Physiological research suggests that TENS inhibits
second order nociceptive neurons (Garrison 1994; Garrison 1996;
Sdrulla 2015), increases blood flow (Chen 2007; Cramp 2001),
and reduces muscle spasms (Avdic 2000). It is plausible that these
actions could alleviate phantom pain, stump pain, or both.
Why it is important to do this review
Systematic reviews of TENS for acute pain have reported positive
outcomes for primary dysmenorrhoea (Proctor 2002), conflicting
outcomes for postoperative pain (Bjordal 2003; Carroll 1996),
and inconclusive outcomes for labour pain (Dowswell 2009). A
Cochrane Review of TENS for acute pain concluded that there is
insufficient evidence to make any definitive conclusions about the
effectiveness of TENS for acute pain in adults (Walsh 2009). Sys-
tematic reviews of TENS for chronic pain have reported positive
outcomes for chronic recurrent headache (Bronfort 2004), and
musculoskeletal pain (Johnson 2007), and inconclusive outcomes
for low back pain (Khadilkar 2008), knee osteoarthritis (Bjordal
2007; Rutjes 2009), rheumatoid arthritis of the hand (Brosseau
2003), post-stroke shoulder pain (Price 2000), cancer-related pain
(Hurlow 2012), and whiplash and mechanical neck disorders
(Kroeling 2013). A Cochrane Review of TENS for chronic pain
concluded that the lack of methodological rigour and robust re-
porting of published literature prevents confident assessment of
the role of TENS in chronic pain management (Nnoaham 2008).
This review has now been withdrawn to be replaced by reviews
on TENS for neuropathic pain in adults (protocol in press) and
TENS for fibromyalgia (protocol in press). Methodological weak-
nesses in randomised controlled trials (RCTs) have been shown
to contribute to low fidelity (Bennett 2011), with more positive
outcomes reported when adequate TENS techniques are taken
into account (Bennett 2011; Bjordal 2003; Bjordal 2007; Sluka
2013). Criteria and operational guidelines for the design of a ro-
bust RCT on TENS have been published by Bennett 2011. TENS
has been recommended as a treatment option for phantom pain
and stump pain (Black 2009; Jensen 2006). Published case series
and controlled clinical trials suggest that TENS may be of ben-
efit (Carabelli 1985; Finsen 1988; Gyory 1977; Katz 1989; Katz
1991; Kawamura 1997; Thorsteinsson 1977;Wartan 1997). Prior
to 2010 there was no systematic review evidence available upon
which to judge the effectiveness of TENS for phantom pain and
stumppain.The originalCochraneReview in2010 concluded that
there was insufficient evidence to make a judgement of effective-
ness. An analysis of excluded studies from the original Cochrane
Review was published in 2014 (Mulvey 2014). This update seeks
to identify new randomised controlled trials published since 2010.
O B J E C T I V E S
To assess the analgesic effectiveness of TENS for the treatment of
phantom pain and stump pain following amputation in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We sought all cross-over or parallel-group randomised controlled
trials (RCTs) investigating the use of TENS for the management
of pain following amputation. We excluded the following: letters,
abstracts and reviews (unless they provided additional information
from published RCTs that met the criteria); studies using exper-
imental pain; case reports; clinical observations; trials that were
non-randomised.
Types of participants
Adult participants (16 years or above) with any limb amputation
resulting in any type of pain in a phantom or stump, or both.
Participants whose amputation had occurred for any reason were
eligible for inclusion in this review.
Types of interventions
We only included trials that evaluated surface electrical nerve stim-
ulation for the management of phantom pain or stump pain, or
both, following amputation (i.e. transcutaneous as opposed to per-
cutaneous electrical stimulation). We included trials only if they:
• used a TENS device that delivered biphasic or monophasic
pulsed electrical currents in the mA range. This included delivery
of currents using the following devices: standard TENS device,
Neuromuscular Electrical Stimulation devices (NMES),
Functional Electrical Stimulation (FES), Interferential Current
devices (IFC) and single electrode probes (i.e. TENS pens);
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• administered TENS at pulse amplitudes that produced
’strong and comfortable’ paraesthesia that was felt by the
participant (i.e. conventional TENS or acupuncture-like TENS,
or both)(TENS delivered at intensities reported to be ’barely
perceptible’, ’faint’ or ’mild’ was excluded);
• administered TENS in an area of the body that was sensate
either at i) the site of pain, ii) over nerve bundles proximal to the
site of pain, iii) on the contralateral limb at the mirror site to the
phantom limb pain, iv) known acupuncture points;
• used any parameters of stimulation providing they met the
above criteria.
The planned intervention comparisons were the following.
• TENS versus no treatment controls.
• TENS versus sham controls. Sham controls are defined as
any electrotherapeutic device that has been modified so that
there is no active output (i.e. dummy device).
• TENS versus a pharmacological intervention.
• TENS versus a non-pharmacological intervention.
It was intended that trials would be excluded from the analysis
if TENS was administered in combination within another inter-
vention as part of the formal trial design; for example additional
analgesics or exercise. It was intended that trials where participants
continued with their usual medications would be included as well
as trials where participants were given rescue medication because
the potential impact on pain scores was thought to be minimal.
Types of outcome measures
Primary outcomes
Patient-reported pain using standard subjective validated scales
(e.g. visual analogue scales (VAS) or numerical rating scales
(NRS)).
Secondary outcomes
• Any other related pain measure designed to capture data
pertaining to the characteristics and quality of pain (e.g. McGill
Pain Questionnaire)
• Patient reported non-painful phantom sensations using
validated scales
• Patient satisfaction
• Activities of daily living and ambulation
• Range of movement*
• Quality of life
• Anxiety/depression




• Other healthcare interventions, e.g. physiotherapy visits,
hospice admissions, day care etc
• Any adverse effects
* Range of movement may not measure the actual range of move-
ment possible but the range of movement that is comfortable.
** If ’sleep’ outcomes are reported these may be heterogeneous and
we planned subcategories in the analysis rather than combining
all sleep outcomes together - we identified no sleep trials so this
was not an issue.
Search methods for identification of studies
For the original version of the review we searched for relevant
trials to February 2010 (Appendix 1). For this update we tailored
searches to individual databases and adapted them from those used
in the original review. This update searched for relevant trials from
2010 to 25 March 2015 (Appendix 2).
We searched the following databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL2015, Issue 2);
• MEDLINE (OVID) 1950 to 25 March 2015;
• EMBASE (OVID) 1980 to 25 March 2015;
• PsycINFO (OVID) 1806 to 25 March 2015;
• AMED (OVID) 1985 to 25 March 2015;
• CINAHL (EBSCO) 1982 to 25 March 2015;
• PEDRO 1929 to 25 March 2015;
• SPORTDiscus (EBSCO) 1975 to 25 March 2015.
We identified trials for inclusion using detailed search strategies
developed for each electronic database. These were based on the
search strategy developed for MEDLINE and we revised them
accordingly for each database. We used medical subject head-
ings (MeSH) or equivalent and text word terms. For the MED-
LINE search, we ran the subject search with the following filter:
Cochrane Highly Sensitive Search Strategy (CHSSS) for identify-
ing randomised controlled trials inMEDLINE (via OVID): sensi-
tivity-maximising version (2008 revision) as referenced inChapter
6.4.11.1 and detailed in box 6.4.a of the Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 (Higgins 2011).
We searched reference lists of all eligible trials, key textbooks and
previous systematic reviews for additional trials.
Language
The search strategy attempted to identify all relevant trials irre-
spective of language. We assessed non-English papers and trans-
lated them if necessary.
Data collection and analysis
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Selection of studies
From the titles, abstracts and descriptors, two independent re-
view authors (MJ and MM) reviewed the results of the literature
searches to identify potentially relevant trials for the full review.
We resolved disagreements through discussion with a third review
author (A-MB). Review authors were not blinded to the authors’
names and institutions, journal of publication, or trial results at
this or any stage of the review.
Data extraction and management
It was intended that the following trial characteristics would be ex-
tracted for entry into RevMan 2014, version 5.3 (RevMan 2014):
authors, participants, trial design, characteristics of interventions
(TENS settings, application, treatment schedules, concurrent in-
terventions), adverse effects andbaseline and endof trial outcomes.
It was intended that two out of three review authors would com-
plete data extraction (MJ, MM) independently. Disagreements
were to be resolved by consensus. Where necessary, we sought ad-
ditional information from trial authors of relevant trials.
Assessment of risk of bias in included studies
In the original review it was intended that the risk of bias of any
included trials would be assessed independently by the review au-
thors. In this update it was intended that two authors (MJ, MM)
would independently assess risk of bias for each trial, using the cri-
teria outlined in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011) and adapted from those used by the
Cochrane Pregnancy and Childbirth Group, with any disagree-
ments resolved by discussion. We planned to complete a ’Risk of
bias’ table for each included trial using the ’Risk of bias tool in
RevMan (RevMan 2014). In this update it was intended that we
would assess the following for each trial:
• Random sequence generation (checking for possible
selection bias). We planned to assess the method used to generate
the allocation sequence as: low risk of bias (any truly random
process, e.g. random number table; computer random number
generator); unclear risk of bias (method used to generate
sequence not clearly stated). Trials using a non-random process
(e.g. odd or even date of birth; hospital or clinic record number)
would be excluded.
• Allocation concealment (checking for possible selection
bias). The method used to conceal allocation to interventions
prior to assignment determines whether intervention allocation
could have been foreseen in advance of, or during recruitment,
or changed after assignment. We planned to assess the methods
as: low risk of bias (e.g. telephone or central randomisation;
consecutively numbered, sealed, opaque envelopes); unclear risk
of bias (method not clearly stated). Trials that do not conceal
allocation (e.g. open list) would be excluded.
• Blinding of outcome assessment (checking for possible
detection bias). We planned to assess the methods used to blind
study participants and outcome assessors from knowledge of
which intervention a participant received. We planned to assess
the methods as: low risk of bias (trial report states that it was
blinded and describes the method used to achieve blinding, e.g.
identical tablets; matched in appearance and smell); unclear risk
of bias (trial report states that it was blinded but does not provide
an adequate description of how it was achieved). Trials that were
not double-blind would be excluded.
• Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data). We planned to assess the methods used to deal
with incomplete data as: low risk (less than 10% of participants
did not complete the study and/or used ’baseline observation
carried forward’ analysis); unclear risk of bias (used ’last
observation carried forward’ analysis); high risk of bias (used
’completer’ analysis).
• Size of trial (checking for possible biases confounded by
small size). We planned to assess studies as being at low risk of
bias (200 participants or more per treatment arm); unclear risk
of bias (50 to 199 participants per treatment arm); high risk of
bias (fewer than 50 participants per treatment arm).
Measures of treatment effect
It was planned that where available and appropriate, data from
outcome measures were to be pooled and presented as an overall
estimate of the effectiveness of TENS. It was intended that the
appropriateness of pooling would first have been assessed on the
basis of clinical heterogeneity in terms of participants, settings, in-
terventions and comparisons, dose intensity, outcomes measured
and timing of outcomemeasurements; and on the basis ofmethod-
ological heterogeneity. For each trial, risk ratio (RR) with 95%
confidence intervals (CI) would be calculated for dichotomous
outcomes. For continuous outcomes reported using the same scale,
pooled results would be presented as mean difference (MD). Stan-
dardised mean differences (SMD) would be calculated where re-
sults for the same continuous outcome had been measured using
different scales. The number needed to treat to benefit (NNTB)
or number needed to treat to harm (NNTH) for treatment effect
would be calculated where appropriate.
Unit of analysis issues
It was intended that if categorical data could not be split into
dichotomous outcomes, they would not be included in a meta-
analysis but would be reported in tables and in the text. In the case
of cross-over trial designs, it was anticipated that the data reported
would not permit analysis of paired within-patient data. Cross-
over trials were intended to be analysed as if they were parallel-
group trials, combining data from all treatment periods. If a carry-
over effect was found and data were reported by period, then
the analysis was to be restricted to period-one data only. In those
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rare cases in which complete data were reported, within-patient
improvement scores were to be calculated. It was intended that if
combining trials in a meta-analysis was not possible, a narrative
description of included trials would be provided.
Dealing with missing data
It was intended that if trials reported outcomes that could not
be included in the meta-analysis, either for reasons already men-
tioned, or because there was missing summary data (e.g. absent
standard deviations) or the report showed that the data evidently
came from a skewed distribution, the trial findings were to be re-
ported in tables and in the text under the appropriate headings.
Assessment of heterogeneity
It was planned that estimates of effectiveness (both SMD and RR)
were to be tested for statistical homogeneity, by visual inspection
of the forest plot and by using the Chi2 test and I2 statistic. The
I2 statistic value would be interpreted according to the following
thresholds (Higgins 2011): 0% to 40%, might not be important;
30%to60%,may representmoderate heterogeneity; 50%to 90%,
may represent substantial heterogeneity; and 75% to 100%, con-
siderable heterogeneity.We planned to investigate any evidence of
heterogeneity to determine if there were obvious differences in the
trials that were likely causes of the heterogeneity. If effect estimates
were consistent with homogeneity, they were to be combined us-
ing a fixed-effect model. If statistical heterogeneity was present,
an attempt would be made to explain the differences based on the
clinical and methodological characteristics of the included trials.
Trials thought to be the cause of statistical heterogeneity would
be excluded from the analysis. Clinically dissimilar trials would
not be statistically combined. However, if a group of trials with
heterogeneous results appeared to be clinically similar, the trial
estimates would be combined using a random-effects model and
the results interpreted with caution.
Subgroup analysis and investigation of heterogeneity
Where the data allowed, it was planned to separate the outcome
analyses to test the following null hypotheses.
1. There is no difference in patient-reported amputee pain for
different causes of amputation.
2. There is no difference in patient-reported amputee pain for
different levels of amputation.
3. There is no difference in patient-reported amputee pain for
different TENS application technique.
Sensitivity analysis
It was planned that a sensitivity analysis would be performedwhen
indicated to investigate the effects of allocation concealment, over-
all methodological quality and use of intention-to-treat (ITT)
analysis. It was intended that trials with high attrition rates (i.e.
more than 50%) would have been removed from themeta-analysis
to see if the results were significantly different without them.
R E S U L T S
Description of studies
There were no trials that met the eligibility criteria in the original
review. Since publication of the original version of this review,
we have found no new trials. In total 72 published reports were
identified by the searches in the original review in 2010 and we
found an additional 85 published reports in this update (Figure 1).
We assessed 14 full-text reports for eligibility in the original review
and we assessed an additional six reports in this update. None of
these met the eligibility criteria for the review (see ’Characteristics
of excluded studies’).
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Figure 1. # of records identified through database searching. Study flow diagram.
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In the original review there were four case reports (Giuffrida
2010; Gyory 1977; Hirano 1988; Katz 1989), eight case series
(Carabelli 1985;Heidenreich 1988; Kawamura 1997;Miles 1978;
Salim 1997; Sindou 1980; Stolke 1978; Winnem 1982), and
two placebo-controlled non-randomised trials (Finsen 1988; Katz
1991). The two placebo-controlled non-randomised trials found
beneficial effects from TENS when compared with placebo (no
current) TENS but neither implemented adequate randomisation
procedures and both failed to report methods of sequence gen-
eration (Finsen 1988; Katz 1991). Katz 1991 reported a “mod-
est reduction” in phantom limb pain after 10 minutes of auric-
ular TENS although no statistical analysis was reported for ac-
tive versus sham TENS. Finsen 1988 reported that low frequency
(2 Hz) segmental TENS reduced healing times and re-amputa-
tion rates when compared to sham TENS but found there was
no difference in analgesic consumption between the groups. No
direct measure of pain was made. Finsen 1988 claimed to have
randomised patients to one of three treatments. However, the au-
thors report that after 18 months there was unequal distribution
of amputation levels between the three groups and recruitment
and randomisation was “...improved by taking into account the
amputation level”. It was felt that the adjustment of recruitment
and randomisation procedures compromised randomisation and
the possibility of purposive sampling cannot be discounted. In this
update the searches found one new case report that investigated
invasive peripheral nerve stimulation (Rauck 2012), one case se-
ries that investigated invasive peripheral nerve stimulation (Rauck
2014), one case series on TENS for phantom pain and stump pain
in adult amputees (Mulvey 2013), and three reviews (Hu 2014;
Lenggenhager 2014; Mulvey 2014).
Risk of bias in included studies
There were no trials included in this review so risk of bias could
not be evaluated.
Effects of interventions
There were no trials included in this review so effects could not
be evaluated.
D I S C U S S I O N
No randomised controlled trials (RCTs) examining the clinical ef-
ficacy of transcutaneous electrical nerve stimulation (TENS) for
the treatment of phantom pain and stump pain in adults were
identified by the searches in the original and this updated review.
Therefore it was not possible to make a judgement about clin-
ical efficacy or effectiveness. The lack of RCTs in this area was
identified in a systematic review by Halbert 2002 and no RCTs
have been published since. The positive trend towards pain re-
lief in some of the excluded case reports, case series and non-ran-
domised trials suggests that TENS may be beneficial for some in-
dividuals and that a large, multicentre, adequately powered RCT
is needed. Careful consideration should be given to randomisa-
tion, allocation concealment, blinding, adequacy of TENS, and
the timing and appropriateness of the outcome measures because
evidence suggests that there are significant sources of potential bias
in both directions in previous RCTs on TENS in other conditions
(Bennett 2011). Suboptimal dosing of TENS and inappropriate
assessment of pain outcomes are particularly prevalent. Criteria
for judging directions of bias in RCTs on TENS, developed by
Bennett 2011, can be adapted to design future trials. In particular,
it is important that TENS is administered to skin with normal
sensation and functional nerves to produce a strong, non-painful
TENS sensation within the receptive field of the area of pain. At-
tempts should also be made to report blinding procedures and
whether blinding was maintained.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Since publication of the original version of this review, we have
found no new trials. There is insufficient evidence from RCTs
to judge whether TENS should, or should not, be used in the
management of phantom pain and stump pain in adults.
Implications for research
A large, multicentre, adequately powered, randomised, placebo-
controlled trial with appropriate procedures for sequence gener-
ation, allocation concealment and blinding is needed. Data pro-
vided in the reports of the excluded studies may prove useful in
calculating sample size. Future studies need to ensure that TENS
is delivered at a strong, non-painful intensity within or close to
the site of pain (Bjordal 2003), using an appropriate technique
in line with best practice (Johnson 2014). Pain outcomes should
be measured whilst the TENS device is switched on, rather than
before and after TENS, and the duration and frequency of each
treatment recorded when TENS is used at home.Means and stan-
dard deviations for continuous data should be reported as standard
to enable data extraction for subsequent meta-analysis.
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(Continued)
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Search strategies for original review
MEDLINE via Ovid search (1950 to February 2010)
[mp=title, original title, abstract, name of substance word, subject heading word]
1. (tens or al-tens or tns or ens or tes).mp.
2. (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”).mp.
3. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
4. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.
5. (“transcutaneous electric*” adj4 stimulat*).mp.
6. (amputat* or amputee*).mp.
7. (postamputation* or post-amputation*).mp.
8. ((phantom adj6 limb) or phantom-limb or stump*).mp.
9. (#4 or #1 or #3 or #2 or #5).
10. (#8 or #6 or #7).
11. (#10 and #9).
Cochrane highly sensitive strategy for identifying randomised trials in MEDLINE: sensitivity-maximising version (2008
revision); Ovid format
12. randomized controlled trial.pt.)








21. (animals not (humans and animals)).sh.
22. 20 not 21
23. 22 and 11
The Cochrane Library search (2010, Issue 1)
1. “tens” or “al-tens” or “tns” or “ens” or “tes”:ti,ab,kw.
2. “transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation” :ti,ab,kw.
3. “electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*” :ti,ab,kw.
4. “electric* nerve therap*” or electroanalgesi* or electro-analgesi* :ti,ab,kw.
5. “transcutaneous electric*” NEAR stimulation :ti,ab,kw.
6. (#1 OR #2 OR #3 OR #4 OR #5).
7. (amputat* or amputee*):ti,ab,kw.
8. (post-amputation* or postamputation*):ti,ab,kw.
9. (phantom-limb or (phantom NEAR limb) or stump* ):ti,ab,kw.
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10. (fantom-limb or (fantom NEAR limb)):ti,ab,kw.
11. (#7 OR #8 OR #9 OR #10).
12. (#6 AND #11).
13. #12 Records from CENTRAL.
EMBASE search via Ovid (1980 to Feb 2010)
[mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name]
1. (tens or al-tens or tns or ens or tes).mp.
2. (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”).mp.
3. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
4. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.
5. (“transcutaneous electric*” adj4 stimulat*).mp.
6. (amputat* or amputee*).mp.
7. (postamputation* or post-amputation*).mp.
8. ((phantom adj6 limb) or phantom-limb or stump*).mp.
9. (#4 or #1 or #3 or #2 or #5).
10. (#8 or #6 or #7).
11. (#10 and #9).




14. (crossover* or cross over* or cross-over*).ti,ab.
15. placebo*.ti,ab.
16. (doubl* adj blind*).ti,ab.






23. RANDOMIZED CONTROLLED TRIAL.sh.
24. SINGLE BLIND PROCEDURE.sh.
25. or(/#12-#24).
26. ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/.
27. HUMAN/.
28. (#26 and #27).
29. (#26 not #28).
30. (#25 not #29).
31. (#11 and #30)
PsycINFO search via Ovid (1806 to February 2010)
[mp=title, abstract, heading word, table of contents, key concepts]
1. (tens or al-tens or tns or ens or tes).mp.
2. (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”).mp.
3. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
4. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.
5. (“transcutaneous electric*” adj4 stimulat*).mp.
6. (amputat* or amputee*).mp.
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7. (postamputation* or post-amputation*).mp.
8. ((phantom adj6 limb) or phantom-limb or stump*).mp.
9. (#4 or #1 or #3 or #2 or #5).
10. (#8 or #6 or #7).
11. (#10 and #9).
AMED via Ovid (Allied and Complementary Medicine) search (1985 to February 2010)
[mp=abstract, heading words, title]
1. (tens or al-tens or tns or ens or tes).mp.
2. (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”).mp.
3. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
4. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.
5. (“transcutaneous electric*” adj4 stimulat*).mp.
6. (amputat* or amputee*).mp.
7. (postamputation* or post-amputation*).mp.
8. ((phantom adj6 limb) or phantom-limb or stump*).mp.
9. (#4 or #1 or #3 or #2 or #5).
10. (#8 or #6 or #7).
11. (#9 and #10)
CINAHL search (1982 to February 2010)
[ti,ab = title, abstract]
1. transcutaneous electrical nerve stimulation.
2. (tens OR al-tens OR tns OR ens OR tes).ti,ab.
3. (“transcutaneous electric* nerve stimulation” OR “transcutaneous nerve stimulation”).ti,ab.
4. (“electric* nerve stimulation” OR “electrostimulation therap*” OR “electro-stimulation therap*”).ti,ab.
5. (“electric* nerve therap*” OR electroanalgesi* OR electro-analgesi*).ti,ab.
6. (“transcutaneous electric*” adj4 stimulat*).ti,ab.
7. (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR # OR #7).
8. exp AMPUTATION/ OR AMPUTATION STUMPS/.
9. (amputat* OR amputee*).ti,ab.
10. (postamputation* OR post-amputation*).ti,ab.
11. ((phantom adj6 limb) OR phantom-limb OR stump*).ti,ab.
12. PHANTOM LIMB/ OR PHANTOM PAIN/.
13. (#8 OR #9 OR #10 OR #11 OR #13).
14. (#7 AND #13).
PEDro search (1929 to February 2010)
[mp=title, abstract]
1. “transcutaneous electric* nerve stimulation”.
2. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
3. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.
4. (amputat* or amputee*).mp.
5. (postamputation* or post-amputation*).mp.
6. “pain”
7. (#1 or #4 or #6).
8. (#1 and #4 and #6)
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SPORTDiscus search (1975 to February 2010)
1. “tens” or “al-tens” or “tns” or “ens” or “tes”:TX
2. “transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”:TX
3. ”electric* nerve stimulation“ or ”electrostimulation therap*“ or ”electro-stimulation therap*“ :TX
4. ”electric* nerve therap*“ or electroanalgesi* or electro-analgesi* :TX
5. ”transcutaneous electric* stimulation“:TX
6. (#1 OR #2 OR #3 OR #4).
7. (amputat* or amputee*):TX
8. (post-amputation* or postamputation*):TX
9. (phantom-limb or (phantom NEAR limb) or stump* ):TX
10. (fantom-limb or (fantom NEAR limb)):TX
11. (#7 OR #8 OR #9 ).
12. (#6 AND #11).
13. (#6 AND #11) and “control trial”: TX
SPORTDiscus search (1975 to February 2010)
1. ”tens“ or ”al-tens“ or ”tns“ or ”ens“ or ”tes“:TX
2. ”transcutaneous electric* nerve stimulation“ or ”transcutaneous nerve stimulation”:TX
3. “electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*” :TX
4. “electric* nerve therap*” or electroanalgesi* or electro-analgesi* :TX
5. “transcutaneous electric* stimulation”:TX
6. (#1 OR #2 OR #3 OR #4).
7. (amputat* or amputee*):TX
8. (post-amputation* or postamputation*):TX
9. (phantom-limb or (phantom NEAR limb) or stump* ):TX
10. (fantom-limb or (fantom NEAR limb)):TX
11. (#7 OR #8 OR #9 ).
12. (#6 AND #11).
13. (#6 AND #11) and “control trial”: TX
Appendix 2. Search strategies for update
MEDLINE (OVID) 2010 to March week 3 2015
1. (tens or al-tens or tns or ens or tes).mp.
2. (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”).mp.
3. Transcutaneous Electric Nerve Stimulation/
4. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
5. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.




10. (amputat* or amputee*).mp.
11. (postamputation* or post-amputation*).mp.
12. ((phantom adj6 limb) or phantom-limb or stump*).mp.
13. or/8-12
14. 7 and 13
15. randomized controlled trial.pt.
16. controlled clinical trial.pt.
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23. 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22
24. exp animals/ not humans.sh.
25. 23 not 24
26. 14 and 25
CENTRAL 2015, Issue 2 (searched 2010 to 2015)
#1 (tens or al-tens or tns or ens or tes):ti,ab,kw (Word variations have been searched)
#2 (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”):ti,ab,kw (Word variations have been searched)
#3 MeSH descriptor: [Transcutaneous Electric Nerve Stimulation] this term only
#4 (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”):ti,ab,kw (Word variations have been
searched)
#5 (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*):ti,ab,kw (Word variations have been searched)
#6 (“transcutaneous electric*” near/4 stimulat*):ti,ab,kw (Word variations have been searched)
#7 #1 or #2 or #3 or #4 or #5 or #6
#8 MeSH descriptor: [Amputation] explode all trees
#9 MeSH descriptor: [Amputees] this term only
#10 (amputat* or amputee*):ti,ab,kw (Word variations have been searched)
#11 (amputat* or amputee*):ti,ab,kw (Word variations have been searched)
#12 ((phantom near/6 limb) or phantom-limb or stump*):ti,ab,kw (Word variations have been searched)
#13 #8 or #9 or #10 or #11 or #12
#14 #7 and #13 Publication Year from 2010 to 2015
EMBASE (OVID) 2010 to 2015 March 24
1. (tens or al-tens or tns or ens or tes).mp.
2. (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”).mp.
3. Transcutaneous Nerve Stimulation/
4. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
5. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.
6. (“transcutaneous electric*” adj4 stimulat*).mp.
7. or/1-6
8. exp Amputation/
9. (amputat* or amputee*).mp.
10. (postamputation* or post-amputation*).mp.
11. ((phantom adj6 limb) or phantom-limb or stump*).mp.
12. or/8-11







20. (doubl$ adj blind$).tw.
21. (singl$ adj blind$).tw.
22. assign$.tw.
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27. Randomized Controlled Trial/
28. Single Blind Procedure/
29. or/14-28
30. (animal/ or nonhuman/) not human/
31. 29 not 30
32. 13 and 31
PsycINFO (OVID) 2010 to March week 3 2015
1. (tens or al-tens or tns or ens or tes).mp.
2. (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”).mp.
3. Transcutaneous Nerve Stimulation/
4. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
5. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.
6. (“transcutaneous electric*” adj4 stimulat*).mp.
7. or/1-6
8. (amputat* or amputee*).mp.
9. (postamputation* or post-amputation*).mp.
10. ((phantom adj6 limb) or phantom-limb or stump*).mp.
11. amputation/ or phantom limbs/
12. or/8-11
13. 7 and 12
AMED (OVID) 2010 to March 2015
1. (tens or al-tens or tns or ens or tes).mp.
2. (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”).mp.
3. Transcutaneous Electric Nerve Stimulation/
4. (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”).mp.
5. (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*).mp.
6. (“transcutaneous electric*” adj4 stimulat*).mp.
7. or/1-6
8. (amputat* or amputee*).mp.
9. (postamputation* or post-amputation*).mp.
10. ((phantom adj6 limb) or phantom-limb or stump*).mp.
11. amputation/ or phantom limb/
12. or/8-11
13. 7 and 12
CINAHL (EBSCO) 2010 to March 2015
S14 S7 AND S13
S13 S8 OR S9 OR S10 OR S11 OR S12
S12 ((phantom N6 limb) or phantom-limb or stump*)
S11 (postamputation* or post-amputation*)
S10 (amputat* or amputee*)
S9 (MH “Amputees”)
S8 (MH “Amputation+”)
S7 S1 OR S2 OR S3 OR S4 OR S5 OR S6
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S6 (“transcutaneous electric*” n4 stimulat*)
S5 (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*)
S4 (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”)
S3 (MH “Transcutaneous Electric Nerve Stimulation”)
S2 (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”)
S1 (tens or al-tens or tns or ens or tes)
SPORTDiscus (EBSCO) 2010 to March 2015
S13 S7 AND S12
Limiters - Published Date: 20100101-20150331
S12 S8 OR S9 OR S10 OR S11
S11 ((phantom N6 limb) or phantom-limb or stump*)
S10 (postamputation* or post-amputation*)
S9 (amputat* or amputee*)
S8 DE “AMPUTEES”
S7 S1 OR S2 OR S3 OR S4 OR S5 OR S6
S6 (“transcutaneous electric*” n4 stimulat*)
S5 (“electric* nerve therap*” or electroanalgesi* or electro-analgesi*)
S4 (“electric* nerve stimulation” or “electrostimulation therap*” or “electro-stimulation therap*”)
S3 (“transcutaneous electric* nerve stimulation” or “transcutaneous nerve stimulation”)
S2 (tens or al-tens or tns or ens or tes)
S1 DE “TRANSCUTANEOUS electrical nerve stimulation”
WH A T ’ S N E W
Last assessed as up-to-date: 25 March 2015.
Date Event Description
11 August 2015 Review declared as stable The authors and editors have agreed that this review will be assessed for further up-
dating in 2020, or earlier if new evidence becomes available
H I S T O R Y
Protocol first published: Issue 3, 2008
Review first published: Issue 5, 2010
Date Event Description
22 May 2015 New citation required but conclusions have not changed We identified 85 published reports in this update. None
met the eligibility criteria for inclusion in the review
22 May 2015 New search has been performed This review has been updated to include the results of a
new search
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(Continued)
3 March 2013 Amended No new trials available. To be assessed for updating in
2015
C O N T R I B U T I O N S O F A U T H O R S
Writing protocol - MM, A-MB, MJ, PM.
Writing original review - MM, A-MB, MJ, PM.
Searching databases - MJ, MM.
Study selection - MJ, MM.
Assessment of methodological quality - MJ, MM, A-MB.
Data extraction - MJ, MM.
Statistical analysis - MJ, MM, A-MB.
Writing updates - MJ, MM, A-MB.
D E C L A R A T I O N S O F I N T E R E S T
Mark I Johnson has no conflicts of interest to declare.
Matthew R Mulvey has no conflicts of interest to declare.
Anne-Marie Bagnall has no conflicts of interest to declare.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
There are no differences between the protocol and the review.
N O T E S
The authors and editors have agreed that this review will be assessed for further updating in 2020, or earlier if new evidence becomes
available.
22Transcutaneous electrical nerve stimulation (TENS) for phantom pain and stump pain following amputation in adults (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Pain Management; ∗Transcutaneous Electric Nerve Stimulation; Amputation Stumps; Phantom Limb [∗therapy]
MeSH check words
Adult; Humans
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